|
US7601691B2
(en)
|
1999-05-17 |
2009-10-13 |
Conjuchem Biotechnologies Inc. |
Anti-obesity agents
|
|
US6887470B1
(en)
|
1999-09-10 |
2005-05-03 |
Conjuchem, Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
|
BR0010750A
(pt)
|
1999-05-17 |
2002-02-26 |
Conjuchem Inc |
Peptìdeos insulinotrópicos de longa duração
|
|
AU2002239414A1
(en)
*
|
2000-11-02 |
2002-05-27 |
Bristol-Myers Squibb Company |
Modified plasminogen related peptide fragments and their use as angiogenesis inhibitors
|
|
BR0206919A
(pt)
*
|
2001-02-02 |
2004-07-06 |
Conjuchem Inc |
Derivados de fator de liberação de hormÈnio de crescimento de longa duração
|
|
DK1360202T3
(da)
|
2001-02-16 |
2008-09-22 |
Conjuchem Biotechnologies Inc |
Langvarigt glucagon-lignende peptid 2 (GLP-2) til behandling af gastrointestinale sygdomme og lidelser
|
|
WO2002083921A2
(en)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
EP2228388A1
(en)
*
|
2001-04-18 |
2010-09-15 |
The Open University |
Protected Arg-Glu-Arg polypeptides and uses thereof
|
|
US7491702B2
(en)
|
2001-04-18 |
2009-02-17 |
The Open University |
Polypeptides related to amyloid precursor protein, pharmaceutical compositions thereof, and methods of treatment using the same
|
|
JP2004536062A
(ja)
*
|
2001-05-17 |
2004-12-02 |
セレメディックス，インク． |
反応性酸素種およびフリーラジカルの効力を中和するためのペプチド化合物
|
|
ATE295370T1
(de)
|
2001-05-31 |
2005-05-15 |
Conjuchem Inc |
Langwirkende fusionspeptid-inhibitoren für hiv- infektion
|
|
US20050026165A1
(en)
*
|
2001-05-31 |
2005-02-03 |
Cindy Orser |
Detection of conformationally altered proteins and prions
|
|
EP1395833B1
(en)
|
2001-05-31 |
2013-02-27 |
Adlyfe, Inc. |
Misfolded protein sensor method
|
|
DK1435999T3
(da)
*
|
2001-10-18 |
2012-10-22 |
Zlatko Ademovic |
Kombination af to bioaktive regioner af pro-opiomelanocortin-hormon
|
|
US6822073B2
(en)
|
2001-12-20 |
2004-11-23 |
Kimberly-Clark Worldwide, Inc. |
Modular peptide-based reagent
|
|
EP1489093A4
(en)
*
|
2002-03-19 |
2005-07-20 |
Oncorex Inc |
PEPTIDES, MEDICAL COMPOSITIONS CONTAINING PEPTIDES, AND MEDICAL COMPOSITIONS FOR THE TREATMENT OF CANCER
|
|
JP2004008027A
(ja)
*
|
2002-06-04 |
2004-01-15 |
Japan Science & Technology Corp |
ｃＡＭＰの産生活性を有する新規ペプチド
|
|
WO2004011595A2
(fr)
*
|
2002-07-26 |
2004-02-05 |
Institut Pasteur |
Vecteurs destines au transfert de molecules d'interet dans des cellules cibles
|
|
JP2006514607A
(ja)
*
|
2002-07-31 |
2006-05-11 |
コンジュケム，インコーポレーテッド |
長時間持続性ナトリウム排泄増加性ペプチド誘導体
|
|
EP1542718B1
(en)
*
|
2002-09-24 |
2015-11-11 |
Dong Xie |
Peptide derivative fusion inhibitors of hiv infection
|
|
US7378495B2
(en)
*
|
2002-10-21 |
2008-05-27 |
Pevion Biotech, Ltd. |
PTH-rP related peptide cancer therapeutics
|
|
AU2003290563A1
(en)
*
|
2002-10-31 |
2004-05-25 |
Clf Medical Technology Acceleration Program, Inc. |
Leptin-related peptides
|
|
JP5068428B2
(ja)
|
2002-11-07 |
2012-11-07 |
アメリカ合衆国 |
血管新生および抗血管新生療法のための標的
|
|
US7648962B2
(en)
|
2002-11-26 |
2010-01-19 |
Biocon Limited |
Natriuretic compounds, conjugates, and uses thereof
|
|
WO2004047871A2
(en)
*
|
2002-11-26 |
2004-06-10 |
Nobex Corporation |
Modified naturetic compounds, conjugates, and uses thereof
|
|
EP1582223A4
(en)
*
|
2003-01-10 |
2007-01-17 |
Niigata Tlo Corp |
VECTOR FOR GENE THERAPY AND METHOD FOR THE QUANTIFICATION OF A TARGET PROTEIN IN MAMMALIAN OR CULTURAL CELLS BY APPLYING THE VECTOR FOR GENE THERAPY
|
|
CN1819839B
(zh)
*
|
2003-01-29 |
2010-06-09 |
李惟 |
免疫调节化合物和相关方法
|
|
DE10316583A1
(de)
*
|
2003-04-10 |
2004-10-28 |
B.R.A.H.M.S Aktiengesellschaft |
Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung
|
|
EP1620734A1
(en)
*
|
2003-04-25 |
2006-02-01 |
Genova Ltd. |
Secreted polypeptide species reduced cardiovascular disorders
|
|
DK1648933T3
(da)
*
|
2003-07-25 |
2009-09-07 |
Conjuchem Biotechnologies Inc |
Langvarige insulinderivater og fremgangsm der
|
|
US8603969B2
(en)
*
|
2004-02-11 |
2013-12-10 |
Amylin Pharmaceuticals, Llc |
Pancreatic polypeptide family motifs and polypeptides comprising the same
|
|
WO2005090399A1
(ja)
*
|
2004-03-24 |
2005-09-29 |
Gifu International Institute Of Biotechnology |
各種細胞の増殖・分化を認識する抗体、その抗体を用いた増殖・分化の評価方法
|
|
EP2369350B1
(en)
*
|
2004-04-20 |
2014-08-20 |
SphingoTec GmbH |
Use of precursors of tachykinins and/or their fragments in medical diagnostic
|
|
CA2559228C
(en)
|
2004-04-21 |
2016-06-21 |
Enobia Pharma Inc. |
Bone delivery conjugates and method of using same to target proteins to bone
|
|
HRP20060362A2
(en)
|
2004-04-23 |
2007-03-31 |
Conjuchem Biotechnologies Inc. |
Method for the purification of albumin conjugates
|
|
ES2363156T3
(es)
*
|
2004-05-13 |
2011-07-22 |
B.R.A.H.M.S Gmbh |
Uso de precursores de encefalinas y/o sus fragmentos en diagnosis médica.
|
|
DE102004043153B4
(de)
*
|
2004-09-03 |
2013-11-21 |
Philipps-Universität Marburg |
Erfindung betreffend GLP-1 und Exendin
|
|
AU2012202855B2
(en)
*
|
2004-09-03 |
2015-02-26 |
Philipps-Universitat Marburg |
GLP-1 and exendin related invention
|
|
AU2005319578A1
(en)
|
2004-11-24 |
2006-06-29 |
Neopro Labs, Llc |
Methods and compositions for treating conditions
|
|
JP4720175B2
(ja)
*
|
2004-12-15 |
2011-07-13 |
富士ゼロックス株式会社 |
マレイミジル基含有材料およびその製造方法
|
|
DE102005003687A1
(de)
|
2005-01-26 |
2006-07-27 |
Sphingo Tec Gmbh |
Immunoassay zur Bestimmung der Freisetzung von Neurotensin in die Zirkulation
|
|
US8372593B2
(en)
|
2005-02-15 |
2013-02-12 |
Adlyfe, Inc. |
Method for detecting misfolded proteins and prions
|
|
WO2006108686A2
(en)
*
|
2005-04-14 |
2006-10-19 |
Aic |
Bnp agonists
|
|
US7833979B2
(en)
|
2005-04-22 |
2010-11-16 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
|
US20080292627A1
(en)
*
|
2005-05-05 |
2008-11-27 |
The Board Of Trustees Of The University Of Illinois |
Compositions and Methods for Treating Mood and Anxiety Disorders
|
|
JP2009513627A
(ja)
*
|
2005-10-27 |
2009-04-02 |
ペプトロン カンパニー リミテッド |
生理活性物質−血液蛋白質複合体及びこれを利用する生理活性物質の安定化方法
|
|
EP2015765A4
(en)
|
2006-03-28 |
2011-11-23 |
Neopro Labs Llc |
METHODS AND COMPOSITIONS FOR TREATING CONDITIONS
|
|
WO2008047241A2
(en)
|
2006-10-16 |
2008-04-24 |
Conjuchem Biotechnologies Inc. |
Modified corticotropin releasing factor peptides and uses thereof
|
|
WO2008052043A2
(en)
*
|
2006-10-24 |
2008-05-02 |
Cogenesys, Inc. |
Opioid receptor agonist fusion proteins
|
|
PE20081140A1
(es)
|
2006-10-25 |
2008-09-22 |
Amgen Inc |
Agentes terapeuticos a base de peptidos derivados de toxinas
|
|
US8592377B2
(en)
|
2007-03-28 |
2013-11-26 |
President And Fellows Of Harvard College |
Stitched polypeptides
|
|
WO2008144675A1
(en)
|
2007-05-17 |
2008-11-27 |
Neopro Labs, Llc |
Crystalline and amorphous forms of peptide
|
|
EP2162540A2
(en)
|
2007-05-22 |
2010-03-17 |
Amgen Inc. |
Compositions and methods for producing bioactive fusion proteins
|
|
WO2009023125A1
(en)
*
|
2007-08-14 |
2009-02-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Neuronostatin and its uses
|
|
JP2010539002A
(ja)
*
|
2007-09-11 |
2010-12-16 |
モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト |
ウロジラチンの治療剤としての使用
|
|
KR20100056508A
(ko)
*
|
2007-09-11 |
2010-05-27 |
몬도바이오테크 래보래토리즈 아게 |
폐렴 연쇄상 구균 감염의 치료를 위한 ｂｆｇｆ １－２４ 및 임의의 （ａｒｇ ８）바소프레신의 용도
|
|
EP2190453A2
(en)
*
|
2007-09-11 |
2010-06-02 |
Mondobiotech Laboratories AG |
Use of trp6-triptorelin and d-leu6-leuprolide as therapeutic agents
|
|
US20100204145A1
(en)
*
|
2007-09-11 |
2010-08-12 |
Dorian Bevec |
Use of a peptide as a therapeutic agent
|
|
AU2009209565B2
(en)
|
2008-02-01 |
2013-09-19 |
Ascendis Pharma As |
Prodrug comprising a self-cleavable linker
|
|
CN102065903B
(zh)
|
2008-04-01 |
2015-02-18 |
诺沃-诺迪斯克有限公司 |
胰岛素清蛋白缀合物
|
|
WO2009142727A2
(en)
*
|
2008-05-19 |
2009-11-26 |
Vasogenix Pharmaceuticals, Inc. |
Sequence modified calcitonin gene related peptides (cgrp)
|
|
AU2010218139B2
(en)
|
2009-02-25 |
2012-11-01 |
Merck Sharp & Dohme Corp. |
Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast Pichia pastoris
|
|
SG177592A1
(en)
*
|
2009-07-29 |
2012-02-28 |
Daiichi Sankyo Co Ltd |
Motilin-like peptide compound having transmucosal absorbability imparted thereto
|
|
US9138462B2
(en)
|
2009-07-31 |
2015-09-22 |
Sanofi-Aventis Deutschland Gmbh |
Prodrugs comprising an insulin linker conjugate
|
|
NZ597964A
(en)
|
2009-07-31 |
2014-04-30 |
Sanofi Aventis Deutschland |
Long acting insulin composition
|
|
CA2779161A1
(en)
*
|
2009-10-28 |
2011-05-05 |
University Of Manitoba |
Yellow pea seed protein-derived peptides
|
|
RU2012140429A
(ru)
|
2010-02-24 |
2014-03-27 |
Мерк Шарп Энд Домэ Корп. |
Способ увеличения занятости участков n-ликозилирования на терапевтических гликопротеинах, продуцируемых в p pastoris
|
|
EP2552951A1
(en)
*
|
2010-03-26 |
2013-02-06 |
Novo Nordisk A/S |
Novel glucagon analogues
|
|
ES2711526T3
(es)
|
2010-08-13 |
2019-05-06 |
Aileron Therapeutics Inc |
Macrociclos peptidomiméticos
|
|
EP2438930A1
(en)
|
2010-09-17 |
2012-04-11 |
Sanofi-Aventis Deutschland GmbH |
Prodrugs comprising an exendin linker conjugate
|
|
WO2012088608A1
(en)
|
2010-12-27 |
2012-07-05 |
Enobia Canada Limited Partnership |
Compositions comprising natriuretic peptides and methods of use thereof
|
|
AU2012311484B2
(en)
|
2011-09-23 |
2017-04-13 |
Novo Nordisk A/S |
Novel glucagon analogues
|
|
TW201806968A
(zh)
|
2011-10-18 |
2018-03-01 |
艾利倫治療公司 |
擬肽巨環化合物
|
|
EP2819688A4
(en)
|
2012-02-15 |
2015-10-28 |
Aileron Therapeutics Inc |
TRIAZOL AND THIOETHER-COUPLED PEPTIDOMIMETIC MACROCYCLES
|
|
BR112014020103A2
(pt)
|
2012-02-15 |
2018-10-09 |
Aileron Therapeutics, Inc. |
macrociclos peptidomiméticos
|
|
JP2013179884A
(ja)
*
|
2012-03-01 |
2013-09-12 |
Mitsubishi Rayon Co Ltd |
メラニンカスケードに関与する成分を評価するための核酸マイクロアレイ及びメラニンカスケードに関与する成分の評価方法
|
|
AU2013263349B2
(en)
|
2012-05-17 |
2016-09-08 |
Extend Biosciences, Inc |
Carriers for improved drug delivery
|
|
US10052366B2
(en)
|
2012-05-21 |
2018-08-21 |
Alexion Pharmaceuticsl, Inc. |
Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
|
|
WO2014071241A1
(en)
|
2012-11-01 |
2014-05-08 |
Aileron Therapeutics, Inc. |
Disubstituted amino acids and methods of preparation and use thereof
|
|
EP2986313B1
(en)
|
2013-04-18 |
2019-06-12 |
Novo Nordisk A/S |
Stable, protracted glp-1/glucagon receptor co-agonists for medical use
|
|
WO2015001015A1
(en)
*
|
2013-07-04 |
2015-01-08 |
Universitat De Barcelona |
Actively transported and protease-resistant peptides as bbb shuttles and shuttle-cargo constructs
|
|
CA2935026C
(en)
*
|
2014-01-15 |
2018-11-13 |
Fyziologicky Ustav Akademie Ved Cr, V.V.I. |
Lipidated prolactin-releasing peptides for lowering blood glucose
|
|
US10570184B2
(en)
|
2014-06-04 |
2020-02-25 |
Novo Nordisk A/S |
GLP-1/glucagon receptor co-agonists for medical use
|
|
WO2016007873A1
(en)
|
2014-07-11 |
2016-01-14 |
The Regents Of The University Of Michigan |
Compositions and methods for treating craniosynostosis
|
|
EP3197478A4
(en)
|
2014-09-24 |
2018-05-30 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
WO2016065042A1
(en)
|
2014-10-22 |
2016-04-28 |
Extend Biosciences, Inc. |
Therapeutic vitamin d conjugates
|
|
US9789197B2
(en)
|
2014-10-22 |
2017-10-17 |
Extend Biosciences, Inc. |
RNAi vitamin D conjugates
|
|
US9616109B2
(en)
|
2014-10-22 |
2017-04-11 |
Extend Biosciences, Inc. |
Insulin vitamin D conjugates
|
|
MX389350B
(es)
|
2014-12-05 |
2025-03-19 |
Alexion Pharma Inc |
Fosfatasas alcalinas recombinantes y usos de las mismas para el tratamiento de convulsiones.
|
|
JP6868561B2
(ja)
|
2015-01-28 |
2021-05-12 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
アルカリホスファターゼ欠損を有する被験者を治療する方法
|
|
ES2740273T3
(es)
*
|
2015-02-22 |
2020-02-05 |
Omnix Medical Ltd |
Péptidos antimicrobianos
|
|
WO2016154058A1
(en)
|
2015-03-20 |
2016-09-29 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
CN108350440A
(zh)
|
2015-08-17 |
2018-07-31 |
阿雷克森制药公司 |
碱性磷酸酯的制造
|
|
JP6868617B2
(ja)
|
2015-09-28 |
2021-05-12 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
低ホスファターゼ血症の組織非特異的アルカリホスファターゼ（ｔｎｓａｌｐ）酵素補充療法に有効な投薬計画の特定
|
|
JP2018533571A
(ja)
|
2015-10-30 |
2018-11-15 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
患者の頭蓋縫合早期癒合症を治療するための方法
|
|
US11530243B2
(en)
*
|
2016-02-18 |
2022-12-20 |
Veiove Animal Health Inc. |
Non-cleavable substance P conjugates and methods of use thereof
|
|
WO2017155569A1
(en)
|
2016-03-08 |
2017-09-14 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in children
|
|
JP7613826B2
(ja)
|
2016-04-01 |
2025-01-15 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
アルカリホスファターゼによって筋力低下を治療すること
|
|
US10898549B2
(en)
|
2016-04-01 |
2021-01-26 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in adolescents and adults
|
|
US10988744B2
(en)
|
2016-06-06 |
2021-04-27 |
Alexion Pharmaceuticals, Inc. |
Method of producing alkaline phosphatase
|
|
EP3500289B1
(en)
|
2016-08-18 |
2024-10-09 |
Alexion Pharmaceuticals, Inc. |
Asfotase alfa for use in treating tracheobronchomalacia
|
|
US12011475B2
(en)
|
2017-03-01 |
2024-06-18 |
Chengdu Huitai Biomedicine Co., Ltd. |
Polypeptide, polypeptide fragment, derivative thereof, and applications thereof
|
|
EP3600383A4
(en)
|
2017-03-31 |
2020-10-28 |
Alexion Pharmaceuticals, Inc. |
METHODS OF TREATMENT OF HYPOPHOSPHATASIA (HPP) IN ADULTS AND ADOLESCENTS
|
|
WO2018221745A1
(ja)
*
|
2017-06-02 |
2018-12-06 |
株式会社Ｌｓｉメディエンス |
生体試料中からの標的タンパク質の抽出方法および標的タンパク質の分析方法
|
|
CN109503700A
(zh)
*
|
2017-09-14 |
2019-03-22 |
南京安吉生物科技有限公司 |
马来酰亚胺基团修饰的血管生成抑制剂hm-1及其应用
|
|
EP3717508A1
(en)
|
2017-12-01 |
2020-10-07 |
The University of Copenhagen |
Peptide hormone with one or more o-glycans
|
|
US11913039B2
(en)
|
2018-03-30 |
2024-02-27 |
Alexion Pharmaceuticals, Inc. |
Method for producing recombinant alkaline phosphatase
|
|
WO2019197313A1
(en)
|
2018-04-09 |
2019-10-17 |
Svar Life Science Ab |
Glucagon Assay
|
|
US12268733B2
(en)
|
2018-08-10 |
2025-04-08 |
Alexion Pharmaceuticals, Inc. |
Methods of treating neurofibromatosis type 1 and related conditions with alkaline phosphatase
|
|
US20220073582A1
(en)
*
|
2018-12-31 |
2022-03-10 |
United Neuroscience Limited |
Peptide immunogens targeting calcitonin gene-related peptide (cgrp) and formulations thereof for prevention and treatment of migraine
|
|
CA3161266A1
(en)
|
2019-12-09 |
2021-06-17 |
Alexion Pharmaceuticals, Inc. |
Alkaline phosphatase polypeptides and methods of use thereof
|
|
IT202000007720A1
(it)
*
|
2020-04-10 |
2021-10-10 |
Alessandra Marconi |
Peptidi e loro usi
|
|
WO2021224938A1
(en)
*
|
2020-05-05 |
2021-11-11 |
Neuland Laboratories Limited |
Improved process for the preparation of semaglutide
|
|
AU2021337652B2
(en)
|
2020-09-04 |
2025-01-30 |
Alexion Pharmaceuticals, Inc. |
Methods for treating bone mineralization disorders
|
|
WO2022115563A1
(en)
*
|
2020-11-25 |
2022-06-02 |
Prolynx Llc |
Extended release hydrogel conjugates of c-natriuretic peptides
|
|
BR112023016048A2
(pt)
|
2021-02-12 |
2023-11-14 |
Alexion Pharma Inc |
Polipeptídeos de fosfatase alcalina e métodos de uso dos mesmos
|
|
KR20250075704A
(ko)
|
2022-09-30 |
2025-05-28 |
익스텐드 바이오사이언시즈, 인크. |
장기-지속형 부갑상선 호르몬
|
|
GB202215797D0
(en)
|
2022-10-25 |
2022-12-07 |
Solasta Bio Ltd |
Insect neuropeptide analogues
|
|
US12245596B1
(en)
|
2023-10-23 |
2025-03-11 |
Solasta Bio Limited |
Insect neuropeptides 8
|
|
US12245588B1
(en)
|
2023-10-23 |
2025-03-11 |
Solasta Bio Limited |
Insect neuropeptides 2
|
|
US12279621B1
(en)
|
2023-10-23 |
2025-04-22 |
Solasta Bio Limited |
Insect neuropeptides 3
|
|
US12281143B1
(en)
|
2023-10-23 |
2025-04-22 |
Solasta Bio Limited |
Insect neuropeptides 1
|
|
US12302908B2
(en)
|
2023-10-23 |
2025-05-20 |
Solasta Bio Limited |
Insect neuropeptides 4
|
|
US12356995B2
(en)
|
2023-10-23 |
2025-07-15 |
Solasta Bio Limited |
Insect neuropeptides 9
|
|
WO2025196125A1
(en)
*
|
2024-03-19 |
2025-09-25 |
Epoqe Pharma Aps |
N-terminally modified calcitonin gene-related peptide analogues
|